Moneycontrol BureauShare price of Hikal touched 52-week high at Rs 256.10, up more than 17 percent intraday Tuesday after the US health regulator issued zero 483 observations for Bangalore facility.The company's active pharmaceutical ingredients (API) and intermediates manufacturing facility located at Jigani, Bangalore was recently inspected by the US Food and Drug Administration (USFDA) in compliance with their requirements.This was a routine inspection by the USFDA, the company said in its filing.At 14:52 hrs Hikal was quoting at Rs 249.95, up Rs 32.75, or 15.08 percent.Posted by Rakesh Patil
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.